To access this element change to forms mode OFF
Grant Award View - GA166498
MoST-LLy (Molecular Screening and Therapeutics in Leukaemia and...
GA ID:
GA166498
Agency:
Department of Health and Aged Care
Approval Date:
17-Apr-2021
Publish Date:
25-May-2021
Category:
Health and Medical Research
Grant Term:
1-Jun-2021 to 31-May-2026
Value (AUD):
$2,688,736.40
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_RCRDUN_RCRDUN_2021_General
Grant Activity:
MoST-LLy (Molecular Screening and Therapeutics in Leukaemia and Lymphoma)
Purpose:
The MoST-Lly clinical trial program will provide a new model of care with rapid molecular screening linked to targeted innovative treatments for the management of high-risk blood cancer in patients in Australia who have exhausted treatment options. MRFF funding will allow this screening and targeted treatment blood cancer screening program to be rolled out nationally, increase trials activity and offer hope to patients with limited treatment options.
GO ID:
GO Title:
MRFF Clinical Trials Activity Initiative – 2020 Rare Cancers, Rare Diseases and Unmet Need General Grant Opportunity
Internal Reference ID:
MRF2006364
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
QIMR Berghofer Medical Research Institute
Recipient ABN:
31 411 813 344
Grant Recipient Location
Suburb:
Herston
Town/City:
Herston
Postcode:
4006
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, SA, WA, QLD, TAS
Postcode:
Multiple
Country:
AUSTRALIA